Literature DB >> 23001405

Eosinophilic esophagitis: current treatment.

Matthew Redd1, Ron Schey.   

Abstract

Eosinophilic esophagitis (EoE) is a relatively new entity with a significant amount of increased recognition over the last decade. The mainstay treatments of EoE are designed to eliminate the causative allergens or to reduce their effects on the esophageal mucosa. Common treatments include dietary modification, proton pump inhibitors, systemic and topical corticosteroids, and endoscopic treatments. As the pathogenesis of EoE is explored, new and novel treatments are being studied that target specific pathways and chemokines identified in as precipitating agents of EoE. This is a rapidly evolving field with significant ongoing research and clinical studies. Our review will therefore focus on current and novel treatment approaches to the disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001405     DOI: 10.1007/s10620-012-2383-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  50 in total

1.  Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis.

Authors:  Alex Straumann; Christian Bussmann; Sébastien Conus; Christoph Beglinger; Hans-Uwe Simon
Journal:  J Allergy Clin Immunol       Date:  2008-08       Impact factor: 10.793

2.  Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids.

Authors:  C A Liacouras; W J Wenner; K Brown; E Ruchelli
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-04       Impact factor: 2.839

3.  Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.

Authors:  Ranjan Dohil; Robert O Newbury; Seema Aceves
Journal:  Dig Dis Sci       Date:  2011-12-02       Impact factor: 3.199

4.  Association of eosinophilic inflammation with esophageal food impaction in adults.

Authors:  Tusar K Desai; Veslav Stecevic; Chung-Ho Chang; Neal S Goldstein; Kamran Badizadegan; Glenn T Furuta
Journal:  Gastrointest Endosc       Date:  2005-06       Impact factor: 9.427

5.  Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications.

Authors:  Evan S Dellon; Wood B Gibbs; Tara C Rubinas; Karen J Fritchie; Ryan D Madanick; John T Woosley; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2010-02-18       Impact factor: 9.427

Review 6.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

7.  Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children.

Authors:  Elizabeth T Schaefer; Joseph F Fitzgerald; Jean P Molleston; Joseph M Croffie; Marian D Pfefferkorn; Mark R Corkins; Joel D Lim; Steven J Steiner; Sandeep K Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2008-02       Impact factor: 11.382

Review 8.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.

Authors:  Glenn T Furuta; Chris A Liacouras; Margaret H Collins; Sandeep K Gupta; Chris Justinich; Phil E Putnam; Peter Bonis; Eric Hassall; Alex Straumann; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2007-08-08       Impact factor: 22.682

9.  Histopathologic variability in children with eosinophilic esophagitis.

Authors:  Ameesh Shah; Amir F Kagalwalla; Nirmala Gonsalves; Hector Melin-Aldana; B U K Li; Ikuo Hirano
Journal:  Am J Gastroenterol       Date:  2009-02-10       Impact factor: 10.864

10.  Eosinophilic oesophagitis: a novel treatment using Montelukast.

Authors:  S E A Attwood; C J Lewis; C S Bronder; C D Morris; G R Armstrong; J Whittam
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more
  2 in total

1.  Current Diagnostic and Treatment Strategies for Eosinophilic Esophagitis.

Authors:  Anna M Lipowska; Robert T Kavitt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-09

2.  Eosinophilic oesophagitis in children: an uncommon occurrence in a predominantly Chinese population in Singapore.

Authors:  Li Nien Michelle Tan; Supriya Srivastava; Ming Teh; Seng Hock Quak; Marion M Aw
Journal:  Singapore Med J       Date:  2016-03-15       Impact factor: 1.858

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.